2001
Epstein-Barr Virus Antibodies and Risk of Multiple Sclerosis: A Prospective Study
Ascherio A, Munger KL, Lennette ET, Spiegelman D, Hernán MA, Olek MJ, Hankinson SE, Hunter DJ. Epstein-Barr Virus Antibodies and Risk of Multiple Sclerosis: A Prospective Study. JAMA 2001, 286: 3083-3088. PMID: 11754673, DOI: 10.1001/jama.286.24.3083.Peer-Reviewed Original ResearchConceptsEpstein-Barr virusViral capsid antigenCases of MSGeometric mean titersHealth Study IIMultiple sclerosisSerum antibody titersRelative riskAntibody titersDisease onsetEBNA-2Health StudyRole of EBVNurses' Health Study IIEBV viral capsid antigenEpstein-Barr virus antibodiesEtiology of MSOccurrence of MSHealthy age-matched controlsNurses' Health StudyCorresponding relative risksCase-control studyAge-matched controlsCMV antigensEBV antibodies
1997
Glutathione S-transferase class mu deletion polymorphism and breast cancer: results from prevalent versus incident cases.
Kelsey KT, Hankinson SE, Colditz GA, Springer K, Garcia-Closas M, Spiegelman D, Manson JE, Garland M, Stampfer MJ, Willett WC, Speizer FE, Hunter DJ. Glutathione S-transferase class mu deletion polymorphism and breast cancer: results from prevalent versus incident cases. Cancer Epidemiology Biomarkers & Prevention 1997, 6: 511-5. PMID: 9232338.Peer-Reviewed Original ResearchConceptsBreast cancerGene deletion polymorphismCase seriesDeletion polymorphismHealth StudyNull genotypeGSTM1 deletionGlutathione S-transferase class muPrevalent breast cancerIncident breast cancerNurses' Health StudyGSTM1 gene deletion polymorphismBreast cancer riskDuration of survivalAge-matched controlsGSTM1 null genotypeBreast cancer prognosisMolecular epidemiologic studiesImproved survivalCigarette smokingIncident casesOdds ratioPrevalent casesEpidemiologic studiesCancer risk